Quick Heal Technologies Limited , a prominent player in the cybersecurity sector, has announced multiple employee stock-related developments under its Employee Stock Option Plan (ESOP) Scheme 2021. The company has granted 48,000 new employee stock options and made two separate allotments of equity shares, demonstrating its continued commitment to employee incentivization.

Latest ESOP Allotment

On December 24, 2025, Quick Heal Technologies allotted 15,352 equity shares under its ESOP Scheme 2021. The company filed the notification under Regulation 10(c) with both BSE and NSE on the same date.

Previous ESOP Activities

Earlier, the company had allotted 32,205 equity shares under the same ESOP Scheme 2021 on November 5, 2025. This previous allotment had distinctive numbers ranging from 7,21,61,177 to 7,21,93,381 and involved multiple exercise prices ranging from ₹10.00 to ₹291.00.

New Stock Option Grant

The Nomination and Remuneration Committee has also approved the grant of 48,000 employee stock options to eligible employees with the following terms:

Share Capital Impact

With the latest allotment of 15,352 shares, combined with the previous allotment of 32,205 shares, Quick Heal Technologies has issued a total of 47,557 new equity shares under its ESOP scheme. The newly allotted shares are identical in all respects to the existing equity shares and will be credited to the company's permanent ISIN INE306L01010 upon receiving final trading approval.

Strategic Significance

These ESOP activities reflect Quick Heal's strategic focus on talent retention and employee motivation in the competitive cybersecurity industry. By aligning employee interests with shareholder value through equity participation, the company aims to foster long-term commitment and drive organizational growth.

Quick Heal Technologies Limited , a prominent player in the cybersecurity software industry, has announced a significant change in its senior management. Mr. Ajit Zanjad, the Vice President Head of Delivery, has tendered his resignation from the company, effective November 28, 2025. The company disclosed this information in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosures Requirement) 2015.

Resignation Details

Mr. Zanjad cited 'professional growth' as the primary reason for his departure. His resignation will impact the company's senior management structure, particularly in the delivery leadership role. The company's statement indicates that the decision was made after discussions that began on August 7, 2025.

Impact on Quick Heal Technologies

The departure of Mr. Zanjad from a key delivery leadership position could potentially affect the company's project execution and delivery capabilities in the short term. However, it's worth noting that such changes in senior management are not uncommon in the dynamic tech industry.

Company's Financial Position

Although not directly related to the resignation, Quick Heal Technologies' recent financial position is noteworthy:

The company has shown modest growth in its asset base and equity over the past year, which could provide a stable foundation as it navigates this leadership transition.

Looking Ahead

As Quick Heal Technologies moves forward, the company will likely focus on ensuring a smooth transition in its delivery leadership. The tech industry's competitive landscape means that the company may need to act swiftly to fill this crucial role to maintain its operational efficiency and market position.

Investors and industry observers will be keen to see how Quick Heal Technologies manages this transition and whether it impacts the company's delivery capabilities or strategic direction in the coming months.